Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02251548
Title A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
Acronym iFCR
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute, Pharmacyclics
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami Sylvester Comprehensive Cancer Center Coral Gables Florida 33146 United States Details
University of Miami Sylvester Comprehensive Cancer Center Deerfield Beach Florida 33442 United States Details
Unversity of Miami Sylvester Comprehensve Cancer Center Miami Florida 33136 United States Details
University of Kansas Cancer Center Westwood Kansas 66205 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
West Michigan Cancer Center Kalamazoo Michigan 49007 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field